تقييم تدبير مرضى المتلازمة الإكليلية الحادة
Abstract
400 مريض 247 رجلا 153 امرأة وسطي أعمارهم 56 سنة كان لديهم متلازمة إكليلية حادة عند القبول قد ضمنوا في هذه الدراسة خلال الفترة بين 1/9/2003 إلى 31/12/2004.
مع متابعة 264 حالة حتى ستة أشهر بعد القبول. تم تحليل المعطيات الديموغرافية، عوامل الخطورة, الإستراتيجيات العلاجية، والوفيات.
التشخيص النهائي كان 40% خناق صدر غير مستقر 60% احتشاء عضلة قلبية.
47% من المرضى وصلوا إلى الإسعاف خلال ست ساعات من بدء الأعراض.
51% من المرضى كانوا مدخنين 25% منهم فقط أقلع عن التدخين بعد ستة أشهر من تاريخ القبول.
92% من المرضى أخذوا هيبارين وأسبرين خلال فترة الاستشفاء مع ملاحظة أن 21%لا يأخذ أي دواء بعد ستة أشهر من القبول.
القثطرة القلبية الإسعافية أجريت فقط ل 37% من المرضى الذين احتاجوها(183 مريضا) خلال فترة الاستشفاء.
39%من مرضى الاحتشاء لم يأخذوا أي دواء حال للخثرة.
400 patients, 247 men and 153 women at average 56 years, who had acute coronary syndrome on admission, were studied from 1/9/2003 to 31/12/2004, and tracing 264 cases up to six months from date of admission. Demographic data, strategic treatments, risk factors and mortality were all discussed and analyzed.
The final diagnosis was unstable angina in 40%myocardial infarction in 60%.
47%of the patients reached the hospital within six hours from symptom onset.
51% of the patients were smoking only 24% of them gave up smoking.
92% of patients took Aspirin and Heparin during hospitalization, noticing that 21% didn't take any medicine after 6 months from date of admission .coronary graphy was made only for 37% of patients who needed it (183 patients) during hospitalization.
39%of myocardial infarction patients didn't receive any thrombolytic medicine.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.